raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:56044

Carcinoma of gallbladder and extrahepatic biliary tract

Synonyms: Carcinoma of gallbladder and EBT

Type
Clinical group
Group
Group of disorders
Inheritance
Not applicable
Age of onset
Adult
Status
active

Carcinoma of the gallbladder (GBC) is the most common and aggressive form of biliary tract cancer (BTC) usually arising in the fundus of the gallbladder, rapidly metastasizing to lymph nodes and distant sites.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enCarcinoma of gallbladder and extrahepatic biliary tractCarcinoma of gallbladder and EBT
frCarcinome de la vésicule biliaire et des voies biliaires extrahépatiquesCarcinome de la vésicule biliaire et des VBEH
deKarzinom der Gallenblase und der extrahepatischen GallengängeGBC · Gallenblasen- und EBT-Karzinom
esCarcinoma de vesícula y vías biliares extrahepáticasCarcinoma de vesícula y VBE · GBC
itCarcinoma della cistifellea e delle vie biliari extraepaticheCarcinoma della cistifellea e delle VBE · GBC
nlCarcinoom van galblaas en extrahepatische galwegenCarcinoom van galblaas en EBT · GBC
ptCarcinoma da vesícula biliar
plRak pęchrzyka żółciowego i zewnątrzwątrobowych przewodów żółciowychGBC · Rak pęchrzyka żółciowego i EBT
csKarcinom žlučníku a extrahepatických žlučových cestKarcinom žlučníku a EBT
ukКарцинома жовчного міхура та позапечінкових жовчовивідних шляхівКарцинома жовчного міхура та ЕБТ
zh胆囊癌和肝外胆管癌胆囊癌和EBT癌
trSafra kesesi karsinomu ve ekstrahepatik safra yollarıSafra kesesi karsinomu ve EBT

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
MONDO0018918Evalidated
MONDO18918Evalidated
UMLSC5566557Evalidated
MedDRA10007426Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

Children (5):

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

7 records
TypeClassValueAreaQualificationValidationSource
Annual incidence1-5 / 10 00012 / 100 000WorldwideValue and classValidatedORPHANET
Annual incidence1-9 / 100 0005.3 / 100 000JapanValue and classNot yet validatedORPHANET
Annual incidence1-9 / 100 0001.5 / 100 000United StatesValue and classNot yet validated13835134[PMID]_17857545[PMID]_13425293[PMID]_22570746[PMID]
Annual incidence1-5 / 10 00014 / 100 000PolandValue and classValidated16397865[PMID]
Annual incidence1-9 / 100 0001.27 / 100 000FranceValue and classNot yet validated10951337[PMID]
Point prevalence1-5 / 10 000—EuropeClass onlyNot yet validatedORPHANET
Annual incidence1-9 / 100 0004.37 / 100 000EuropeValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card